Hence, the reduction in serum Alb concentration not only reflects hepatic insufficiency, but also indicates the lack of human defense capabilities, like cellular immunity and humoral immunity, which may thus increase the possibility of human infection and lead to poor response to anti-cancer treatment (26). The gene discussed is ALB; the disease is infection.